Drug Trial Radar · NCT01973790
Phase III, Long-term, Open-label Safety Study of Z-338
Last checked: Nov 19, 2026Latest source record: Jun 28, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
207
Actual
Start
Mar 2014
Primary completion
Nov 2016
Study completion Apr 2017
Sponsor
- Lead sponsor
- Zeria PharmaceuticalIndustry
- Sponsor type
- Industry
- First posted
- Nov 1, 2013
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of this study is to evaluate the long-term safety of 100 mg Z-338 TID in European subjects with FD.
Conditions
- Dyspepsia
Interventions
Z-338Drug
100mg TID
Primary outcomes
What the sponsor says the trial is designed to measure.
- General safety endpointsTime frame: up to 58 weeks
Locations
36 sites in 10 countries. Site status is shown where the registry gives one.
Zeria Investigative site
Leuven, Belgium
Zeria Investigative Site
Plovdiv, Bulgaria
Zeria Investigative Sites
Sofia, Bulgaria
Zeria Investigative site
Varna, Bulgaria
Zeria Invetigative Site
Liepāja, Latvia
Zeria Investivgative SIte
Limbaži, Latvia
Zeria Investigative Sites
Riga, Latvia
Zeria Investigative Site
Alytus, Lithuania
Zeria Investigative Sites
Kaunas, Lithuania
Zeria Investigative Site
Klaipėda, Lithuania
Zeria Investigative Site
Vilnius, Lithuania
Zeria Investigative Site
Brasov, Romania
Zeria Investigative Sites
Bucharest, Romania
Zeria Investigative Sites
Cluj-Napoca, Romania
Zeria Investigative Site
Sibiu, Romania
Zeria Investigative Site
Târgu Mureş, Romania
Zeria Investigative Sites
Timișoara, Romania
Zeria Investigative Site
Kazan', Russia
Zeria Investigative Site
Ryazan, Russia
Zeria Investigative Site
Saratov, Russia
Zeria Investigative Site
Yaroslavl, Russia
Zeria Investigative sites
Bratislava, Slovakia
Zeria Investigative sites
Košice, Slovakia
Zeria Investigative Site
Malacky, Slovakia
Zeria Investigative Site
Martin, Slovakia
Zeria Investigative Site
Nitra, Slovakia
Zeria Investigative Site
Prešov, Slovakia
Zeria Investigative Site
Trnava, Slovakia
Zeria Investigative Site
Gothenburg, Sweden
Zeria Investigative Sites
Stockholm, Sweden
Zeria Investigative Site
Dnipropetrovsk, Ukraine
Zeria Investigative Site
Kyiv, Ukraine
Zeria Investigative Site
Vinnytsia, Ukraine
Zeria Investigative site
Barnstaple, United Kingdom
Zeria Investigative site
Bath, United Kingdom
Zeria Investigative Site
Royal Leamington Spa, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.